May 5, 2020 / 9:59 PM / 25 days ago

BRIEF-Jazz Pharmaceuticals Announces First Quarter 2020 Financial Results

May 5 (Reuters) - Jazz Pharmaceuticals PLC:

* JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.45

* Q1 GAAP LOSS PER SHARE $2.82

* Q1 REVENUE $535 MILLION VERSUS REFINITIV IBES ESTIMATE OF $544.5 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $0.67 — REFINITIV IBES DATA

* CASH AND INVESTMENTS OF $1 BILLION AT QUARTER END

* 2020 FULL-YEAR REVENUE GUIDANCE REDUCED DUE TO ANTICIPATED IMPACT OF COVID-19 PANDEMIC

* SEES 2020 REVENUES $2,120 MILLION - $2,260 MILLION

* FY2020 REVENUE VIEW $2.30 BILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below